CoughLess Trezmi | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

110 results for “CoughLess Trezmi”

Trials

View all 77 →

Safety and Effectiveness of VYC-12 Hyaluronic Acid Injectable Gel for Treatment of Superficial Cutaneous Depressions

134 participants · First posted Aug 24, 2016

Surface Texture and Clinical Performance of Milled BioHPP Polyetheretherketone (PEEK) Single Posterior Crowns Veneered With Two Different Techniques

26 participants · First posted Jun 10, 2021

CTRI/2018/11/016246

Touchless camera based monitoring of health parameters

158 participants

Drugs

View all 10 →

Investigational

Treamid

64Cu-TREM1-mAb

TREM2 Targeting Aptamers (Novartis)

Organizations

ALI REZAI

Australia

Trevi Therapeutics, Inc.

United States

Centre Hospitalier Interrégional Edith Cavell - Les Cliniques et Hôpitaux de la BasilIque, de Braine-l'Alleud - Waterloo, Edith Cavell, Lambermont, du Parc Léopold, Sainte-Anne Saint-Remi et de Delta

Belgium

News

View all 20 →

United Therapeutics Outlines 14 Planned Launches Across Pulmonary Fibrosis, Hypertension and Xenotransplantation

DEBRA Research and Dermaliq Partner to Develop Touchless Drug Delivery for Epidermolysis Bullosa

Ligand-Independent Strategies May Overcome Challenges in TREM-1 and TREM-2 Inhibition

Page 1 of 11